Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Major Depressive Disorder (MDD) is a prevalent, chronic, disabling, and multidimensional mental disorder. Cognitive dysfunction represents a core diagnostic and symptomatic criterion of MDD, and is a principal determinant of functional non-recovery. Cognitive impairment has been observed to persist despite remission of mood symptoms, suggesting dissociability of mood and cognitive symptoms in MDD. Recurrent impairments in several domains including, but not limited to, executive function, learning and memory, processing speed, and attention and concentration, are associated with poor psychosocial and occupational outcomes. Attempts to restore premorbid functioning in individuals with MDD requires regular screenings and assessment of objective and subjective measures of cognition by clinicians. Easily accessible and cost-effective tools such as the THINC-integrated tool (THINC-it) are suitable for use in a busy clinical environment and appear to be promising for routine usage in clinical settings. However, antidepressant treatments targeting specific cognitive domains in MDD have been insufficiently studied. While select antidepressants, e.g., vortioxetine, have been demonstrated to have direct and independent pro-cognitive effects in adults with MDD, research on additional agents remains nascent. A comprehensive clinical approach to cognitive impairments in MDD is required. The current narrative review aims to delineate the importance and relevance of cognitive dysfunction as a symptomatic target for prevention and treatment in the phenomenology of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“Brain imaging evidence in MDD reveals a pattern of increased activity in the limbic system coincident with decreased activity in executive areas of the brain (49).”
BackgroundCognitive vulnerability to emotional disorders
Mathews, A., & MacLeod, C. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143916 · Cited by 2,100
The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry
Insel, T. R. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020138 · Cited by 1,472
Pascual-Leone, A., Rubio, B., Pallardó, F., & Catalá, M. D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01219-6 · Cited by 1,229
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · cited 1×
“The use of CBT in combination with pharmacotherapy in adult depression has been shown to target primarily hot cognitive processes and be more effective than pharmacotherapy alone (54).”
BackgroundCognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · cited 5×
“Cognitive behavior therapy (CBT) is a well-studied and propitious therapeutic avenue for the treatment andmanagement of cognitive dysfunction inMDD.”
BackgroundInfluentialMcIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Self-citationIn Search of the Emotional Self: An fMRI Study Using Positive and Negative Emotional Words
Fossati, P., Hevenor, S. J., Graham, S. J., Grady, C., Keightley, M. L., Craik, F., & Mayberg, H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1938 · Cited by 635 · cited 1×
“However, it is important to note that the weighted significance and distinction between “hot” and “cold” cognition in depressed individuals is non-discrete and there are many overlapping features between the two constructs (20, 21).”
BackgroundCognitive impairment in euthymic major depressive disorder: a meta-analysis
Bora, E., Harrison, B. J., Yücel, M., & Pantelis, C. (2013) · Psychological Medicine · doi:10.1017/s0033291712002085 · Cited by 551
Research works printed but not linked: 40
- 2017, Depression and Other Common Mental Disorders Global Health
- Jacobs, 2009, PMH31 measuring the economic burden of depression using patient records, Value Health, 12, A356, 10.1016/S1098-3015(10)74750-1 · doi:10.1016/s1098-3015(10)74750-1
- Lépine, 2011, The increasing burden of depression, Neuropsychiatric Dis Treatmen, 7, 3, 10.2147/NDT.S19617 · DOI · Paper page
- Zimmerman, 2006, Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined, Psychiatry Res, 141, 185, 10.1016/j.psychres.2005.05.016 · DOI
- Stedman, 2012, Stedman's Medical Dictionary for the Health Professions and Nursing.
- 2013, In Diagnostic and Statistical Manual of Mental Disorders
- Cserjési, 2009, Altered executive function in obesity. exploration of the role of affective states on cognitive abilities, Appetite., 52, 535, 10.1016/j.appet.2009.01.003 · DOI · Paper page
- Larochette, 2011, Additive Neurocognitive Deficits in Adults with attention-deficit/hyperactivity disorder and depressive symptoms, Arch Clin Neuropsychol., 26, 385, 10.1093/arclin/acr033 · DOI
- Mansur, 2014, Diabetes mellitus and disturbances in brain connectivity: abidirectional relationship?, Neuromol Med., 16, 658, 10.1007/s12017-014-8316-8 · DOI
- Thomas, 2009, A comparison of neurocognitive impairment in younger and older adults with major depression, Psychol Med., 39, 725, 10.1017/S0033291708004042 · DOI · Paper page
- Gildengers, 2012, Cognition in older adults with bipolar disorder versus major depressive disorder, Bipolar Disord., 14, 198, 10.1111/j.1399-5618.2012.00995.x · DOI · Paper page
- Withall, 2010, A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder, J Affect Disord., 123, 150, 10.1016/j.jad.2009.07.012 · DOI
- Pan, 2017, Pharmacological treatment of cognitive symptoms in major depressive disorder, CNS Neurol Disord. - Drug Targets, 16, 1, 10.2174/1871527316666170919115100 · DOI
- Lemos-Miller, 2006, Depression and ethnicity as intermediary variables among dissociation, trauma-related cognitions, and PTSD Symptomatology in Youths, J Nervous Mental Dis., 194, 584, 10.1097/01.nmd.0000230407.12687.ba · DOI · Paper page
- Park, 2018, Predicting antidepressant response using early changes in cognition: a systematic review, Behav Brain Res., 353, 154, 10.1016/j.bbr.2018.07.011 · DOI
- McIntyre, 2015, The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project, Comprehens Psychiatry, 56, 279, 10.1016/j.comppsych.2014.08.051 · DOI
- Ott, 2016, Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools, J Affect Disord., 190, 607, 10.1016/j.jad.2015.10.059 · DOI · Paper page
- Mackin, 2013, The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment, Am J Geriat Psychiatry, 21, 906, 10.1016/j.jagp.2013.01.021 · DOI · Paper page
- Lee, 2013, Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients, Psychol Med., 43, 1161, 10.1017/S0033291712002127 · DOI · Paper page
- Naismith, 2011, Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program, Am J Geriatr Psychiatry, 19, 240, 10.1097/JGP.0b013e3181dba587 · DOI
- Lemogne, 2012, Medial prefrontal cortex and the self in major depression, J Affect Disord., 136, e1, 10.1016/j.jad.2010.11.034 · DOI · Paper page
- Yoshimura, 2010, Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity, J Affect Disord., 122, 76, 10.1016/j.jad.2009.06.017 · DOI · Paper page
- Yoshimura, 2017, Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices, J Affect Disord., 208, 610, 10.1016/J.JAD.2016.10.017 · DOI
- Semkovska, 2010, Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis, 68, 568, 10.1016/j.biopsych.2010.06.009 · DOI · Paper page
- Miskowiak, 2014, “Hot” cognition in major depressive disorder: a systematic review, CNS Neurol Disord Drug Targets, 13, 1787, 10.2174/1871527313666141130205713 · DOI · Paper page
- Miskowiak, 2007, Single dose antidepressant administration modulates the neural processing of self-referent personality trait words, NeuroImage, 37, 904, 10.1016/j.neuroimage.2007.05.036 · DOI
- Nathan, 2014, Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery, Curr Opin Pharmacol., 14, 54, 10.1016/j.coph.2013.11.009 · DOI
- Rasmussen, 2011, Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression, J ECT, 27, 51, 10.1097/YCT.0b013e3181da84c6 · DOI · Paper page
- Ressler, 2001, Role of norepinephrine in the pathophysiology of neuropsychiatric disorders, CNS Spectrums., 6, 663, 10.1017/S1092852900001358 · DOI · Paper page
- FDA Updates Trintellix® (vortioxetine) Label to Include Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in acute Major Depressive Disorder (MDD).2018
- Rowland, 2005, Selective cognitive impairments associated with NMDA receptor blockade in humans, Neuropsychopharmacology, 30, 633, 10.1038/sj.npp.1300642 · DOI · Paper page
- Krystal, 1999, Interactive effects of subanesthetic ketamine and haloperidol in healthy humans, Psychopharmacology, 145, 193, 10.1007/s002130051049 · DOI · Paper page
- Morgan, 2004, Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers, Neuropsychopharmacology., 29, 208, 10.1038/sj.npp.1300342 · DOI · Paper page
- Price, 2014, Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression, Depress Anxiety, 31, 335, 10.1002/da.22253 · DOI · Paper page
- Bunn, 2013, Erythropoietin, Cold Spring Harbor Perspect Med., 3, a011619, 10.1101/cshperspect.a011619 · DOI · Paper page
- Miskowiak, 2012, Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression, Psychopharmacology, 219, 687, 10.1007/s00213-011-2511-1 · DOI
- Sun, 2018, Exercise for cognitive symptoms in depression: a systematic review of interventional studies, Can J Psychiatry, 63, 115, 10.1177/0706743717738493 · DOI · Paper page
- Reger, 2008, Intranasal insulin improves cognition and modulates -amyloid in early AD, Neurology., 70, 440, 10.1212/01.WNL.0000265401.62434.36 · DOI · Paper page
- Craft, 2012, Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial, Archi Neurol., 69, 29, 10.1001/archneurol.2011.233 · DOI · Paper page
- Cha, 2017, A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder, J Affect Disord., 210, 57, 10.1016/j.jad.2016.12.006 · DOI
Cited by
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Microglia regulation of synaptic plasticity and learning and memory
Zhou, M., Cornell, J., Salinas, S., & Huang, H.-Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.322423 · Cited by 548
“Microglial activation or dysfunction is associated with the progression of cognitive deficits in normal aging, neurodegenerative and neurological diseases such as Alzheimer’s disease (AD), traumatic brain injury (TBI) and HIV-associated neurocognitive disorder (HAND), and mental disorders including autism, stress and…”
BackgroundInfluentialAnimal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Self-citationPaying attention to attention in depression
Keller, A. S., Leikauf, J. E., Holt-Gosselin, B., Staveland, B. R., & Williams, L. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0616-1 · Cited by 329
Ho, C. S. H., Lim, L. J. H., Lim, A. Q., Chan, N. H. C., Tan, R. S., Lee, S. H., & Ho, R. C. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00378 · Cited by 221
“Cognitive dysfunction occurs in patients who are depressed, of which impairments in executive ability is one of the core domains, in addition to learning/memory, attention/ concentration, and processing speed (95).”
BackgroundAlavi, N., Moghimi, E., Stephenson, C., Gutierrez, G., Jagayat, J., Kumar, A., Shao, Y., Miller, S., Yee, C. S., Stefatos, A., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1113956 · Cited by 36
“The in-person and e-CBT content were intended to mirror one another and focused on: (1) an introduction to depression and the 5-part model (39), which encourage conceptualization of a specific situation or environment through an interlink of thoughts, feelings, physical reactions, and behaviours, (2) the Thought Recor…”
BackgroundMonocyte Chemoattractant Protein-1 Levels Are Associated with Major Depressive Disorder
Proma, M. A., Daria, S., Nahar, Z., Ashraful Islam, S. M., Bhuiyan, M. A., & Islam, M. R. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0132 · Cited by 29
Dealing with heterogeneity of cognitive dysfunction in acute depression: A clustering approach
Vicent-Gil, M., Portella, M. J., Serra-Blasco, M., Navarra-Ventura, G., Crivillés, S., Aguilar, E., Palao, D., & Cardoner, N. (2021) · Psychological Medicine · doi:10.1017/s0033291720001567 · Cited by 28
“vortioxetine, duloxetine, modafinil or erythropoietin), non-pharmacological approaches (cognitive remediation or aerobic exercise) and neurostimulation interventions have been shown to be effective in the treatment of cognitive dysfunction while improving psychosocial functioning and quality of life (Salagre et al., 2…”
BackgroundAlzarea, S., Abbas, M., Ronan, P. J., Lutfy, K., & Rahman, S. (2022) · Brain Sciences · doi:10.3390/brainsci12111493 · Cited by 17
Pan, W.-G., Hu, X.-Y., Zhu, D.-D., Li, L., Bao, F., Ren, L., Mao, P.-X., Ma, X., Ren, Y.-P., & Tang, Y.-L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240261 · Cited by 12
Zhang, Y., Lai, S., Zhang, J., Wang, Y., Zhao, H., He, J., Huang, D., Chen, G., Qi, Z., Chen, P., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.272 · Cited by 11
Guidetti, C., Serra, G., Pani, L., Pappagallo, M., Maglio, G., Martin, S. D., Mattarei, A., Folli, F., Manfredi, P. L., & Fava, M. (2023) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.22m03267 · Cited by 4
Mishra, S., Mudgal, V., Bagul, K. R., Jain, P., & Pal, V. (2025) · Cureus · doi:10.7759/cureus.79365 · Cited by 1
Metadata
- Authors
- Zuckerman, H., Pan, Z., Park, C., Brietzke, E., Musial, N., Shariq, A. S., Iacobucci, M., Yim, S. J., Lui, L. M. W., Rong, C., & McIntyre, R. S.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2018-12-04
- Volume
- 9
- Pages
- 655-655
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2902778000
- Cited by
- 252
- References
- 53
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.